Walleye Capital’s BioPlus Acquisition Corp. Unit BIOSU Stock Holding History

Walleye Capital’s Portfolio BIOSU Stock Details BIOSU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-50,103	Closed	-$525K	–	5050
2023 Q1	$525K	Hold	50,103	–	–	0.01%	1673
2022 Q4	$511K	Sell	50,103 -12	-0%	-$122	0.01%	1437
2022 Q3	$504K	Hold	50,115	–	–	0.01%	1464
2022 Q2	$504K	Hold	50,115	–	–	0.01%	1024
2022 Q1	$500K	Sell	50,115 -13,885	-22%	-$139K	0.01%	1013
2021 Q4	$640K	Buy	+64,000	New	+$641K	0.02%	843

Other funds holding BIOSU

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Clear Street New York $39.5B AUM 124.03% 1-Year Est. Return

Walleye Capital's BIOSU Position: Q2 2023 in Review

Walleye Capital sold out of BioPlus Acquisition Corp. Unit (BIOSU) in Q2 2023, closing a stake of 50,103 shares — an estimated $525K sold.

Walleye Capital first reported a position in BIOSU in Q4 2021 and held it in 6 quarters. The position peaked at $640K in Q4 2021. 2 funds tracked by Wall St. Rank hold BIOSU as of Q2 2023.

Walleye Capital reported no remaining BioPlus Acquisition Corp. Unit position as of Q2 2023 after selling out during the quarter.
Walleye Capital sold 50,103 BioPlus Acquisition Corp. Unit shares in Q2 2023, an estimated $525K.
Walleye Capital first reported a position in BioPlus Acquisition Corp. Unit in Q4 2021 and held it in 6 quarters.
Walleye Capital's BioPlus Acquisition Corp. Unit position peaked at $640K in Q4 2021.
2 funds tracked by Wall St. Rank held BioPlus Acquisition Corp. Unit as of Q2 2023.

Based on Walleye Capital's 13F filing for Q2 2023, filed 14 Aug 2023.